Dumurgier, Julien

Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum.

Benedet, A. L., Milà-Alomà, M., Vrillon, A., Ashton, N. J., Pascoal, T. A., Lussier, F., Karikari, T. K., Hourregue, C., Cognat, E., Dumurgier, J., et al. (2021) · JAMA Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 638

Association of sleep duration in middle and old age with incidence of dementia

Sabia, S., Fayosse, A., Dumurgier, J., van Hees, V. T., Paquet, C., Sommerlad, A., Kivimäki, M., Dugravot, A., & Singh-Manoux, A. (2021) · Nature Communications

Dementia and Cognitive Impairment ResearchSleep and related disorders

Cited by 628

Association between age at diabetes onset and subsequent risk of dementia

Barbiellini Amidei, C., Fayosse, A., Dumurgier, J., Machado-Fragua, M. D., Tabak, A. G., van Sloten, T., Kivimäki, M., Dugravot, A., Sabia, S., & Singh-Manoux, A. (2021) · JAMA

Dementia and Cognitive Impairment ResearchDiabetes Treatment and Management

Cited by 355

Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study

Dumurgier, J., Elbaz, A., Ducimetiere, P., Tavernier, B., Alperovitch, A., & Tzourio, C. (2009) · BMJ

Frailty in Older AdultsBalance, Gait, and Falls Prevention

Cited by 344

Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study

Sabia, S., Fayosse, A., Dumurgier, J., Schnitzler, A., Empana, J.-P., Ebmeier, K. P., Dugravot, A., Kivimäki, M., & Singh-Manoux, A. (2019) · BMJ

Dementia and Cognitive Impairment ResearchCardiovascular Health and Risk Factors

Cited by 205

Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia

Bergeron, D., Gorno‐Tempini, M. L., Rabinovici, G. D., Santos‐Santos, M. A., Seeley, W., Miller, B. L., Pijnenburg, Y., Keulen, M. A., Groot, C., van Berckel, B. N. M., et al. (2018) · Annals of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 203

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Hansson, O., Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C., & Blennow, K. (2016) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 184

Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls

Bellenguez, C., Charbonnier, C., Grenier-Boley, B., Quenez, O., Le Guennec, K., Nicolas, G., Chauhan, G., Wallon, D., Rousseau, S., Richard, A. C., et al. (2017) · Neurobiology of Aging

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 166

Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis

Karikari, T. K., Emeršič, A., Vrillon, A., Lantero‐Rodriguez, J., Ashton, N. J., Kramberger, M. G., Dumurgier, J., Hourregue, C., Čučnik, S., Brinkmalm, G., et al. (2021) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 143

Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability

Therriault, J., Janelidze, S., Benedet, A. L., Ashton, N. J., Arranz Martínez, J., Gonzalez-Escalante, A., Bellaver, B., Alcolea, D., Vrillon, A., Karim, H., et al. (2024) · Nature Aging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 131

SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease

Nicolas, G., Charbonnier, C., Wallon, D., Quenez, O., Bellenguez, C., Grenier-Boley, B., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., Le Guennec, K., et al. (2016) · Molecular Psychiatry

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 129

Sex differences and the role of education in cognitive ageing: analysis of two UK-based prospective cohort studies

Bloomberg, M., Dugravot, A., Dumurgier, J., Kivimaki, M., Fayosse, A., Steptoe, A., Britton, A., Singh-Manoux, A., & Sabia, S. (2021) · The Lancet Public Health

Dementia and Cognitive Impairment ResearchCognitive Abilities and Testing

Cited by 114

Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly

Chhatwal, J. P., Schultz, A. P., Marshall, G. A., Boot, B., Gomez-Isla, T., Dumurgier, J., LaPoint, M., Scherzer, C., Roe, A. D., Hyman, B. T., et al. (2016) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 106

Hypertension and lower walking speed in the elderly: the three-City study

Dumurgier, J., Elbaz, A., Dufouil, C., Tavernier, B., & Tzourio, C. (2010) · Journal of Hypertension

Blood Pressure and Hypertension StudiesBalance, Gait, and Falls Prevention

Cited by 90

ABCA7 rare variants and Alzheimer disease risk

Le Guennec, K., Nicolas, G., Quenez, O., Charbonnier, C., Wallon, D., Bellenguez, C., Grenier-Boley, B., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., et al. (2016) · Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 69

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease

Boza-Serrano, A., Vrillon, A., Minta, K., Paulus, A., Camprubí-Ferrer, L., Garcia, M., Andreasson, U., Antonell, A., Wennström, M., Gouras, G., et al. (2022) · Acta Neuropathologica

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 66

Motor function in the elderly: Evidence for the reserve hypothesis

Elbaz, A., Vicente-Vytopilova, P., Tavernier, B., Sabia, S., Dumurgier, J., Mazoyer, B., Singh-Manoux, A., & Tzourio, C. (2013) · Neurology

Dementia and Cognitive Impairment ResearchCerebrovascular and genetic disorders

Cited by 65

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024) · Journal of Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 28

Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer’s Disease Diagnosis in Cognitively Impaired Patients

Lilamand, M., Bouaziz-Amar, E., Dumurgier, J., Cognat, E., Hourregue, C., Mouton-Liger, F., Sanchez, M., Troussière, A.-C., Martinet, M., Hugon, J., et al. (2023) · The Journals of Gerontology: Series A

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 27

Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia

Marelli, C., Hourregue, C., Gutierrez, L.-A., Paquet, C., Menjot de Champfleur, N., De Verbizier, D., Jacob, M., Dubois, J., Maleska, A. M., Hirtz, C., et al. (2020) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 21

Contribution of smoking towards the association between socioeconomic position and dementia: 32-year follow-up of the Whitehall II prospective cohort study

Raggi, M., Dugravot, A., Valeri, L., Machado-Fragua, M. D., Dumurgier, J., Kivimaki, M., Sabia, S., & Singh-Manoux, A. (2022) · The Lancet Regional Health - Europe

Dementia and Cognitive Impairment ResearchHealth disparities and outcomes

Cited by 18